Safety of ICL670 vs. Deferoxamine in Sickle Cell Disease Patients With Iron Overload Due to Blood Transfusions

This study has been completed.

Study NCT00067080 Information provided by Novartis

First Received: August 11, 2003 Last Updated: September 21, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	December 2003
Estimated Primary Completion Date:	No date given